Clik here to view.
St. Luke’s Medical Center-Global City Trusts UpToDate to Support Exceptional...
WALTHAM, Mass. Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that St. Luke’s Medical Center-Global City is among the...
View ArticleClik here to view.
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS®...
SAN FRANCISCO Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced four-year overall survival (OS) data from the ADCETRIS (brentuximab vedotin)...
View ArticleClik here to view.
Real-Time, Responsive, Actionable Advice: ARDA Coaching Engine; a...
SAN FRANCISCO Performance Lab, developer of automated technology for fitness and health applications, today unveils the ARDATM Coaching Engine, a new, patented software platform that will redefine...
View ArticleClik here to view.
Ecolab Commits $1.5 Million to the Project WET Foundation to Support Water...
ST. PAUL, Minn. Ecolab Inc., the global leader in water, hygiene and energy technologies and services, has committed $1.5 million through the Ecolab Foundation to the Project WET Foundation, a...
View ArticleClik here to view.
Increasing Awareness of Bone Health Will Fast-track the Osteoporosis Drugs...
LONDON TechNavio has announced the publication of a new market research report on the Osteoporosis Drugs Market in APAC Region, which is expected to grow at a CAGR of 4.73 percent from 2015-2019....
View ArticleClik here to view.
武田呈报研究中的Ixazomib单药用于新诊断多发性骨髓瘤患者巩固治疗的2期数据
旧金山 (美国商业资讯) — 武田药品工业株式会社(TSE:4502)今天发布了一项2期开放研究的结果，该研究评估口服ixazomib...
View ArticleClik here to view.
Otsuka and Lundbeck Present Phase III Data on Brexpiprazole as Adjunctive...
TOKYO & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced the presentation of Phase III study results evaluating the efficacy of...
View ArticleClik here to view.
Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce...
TOKYO & OSAKA, Japan & NEW YORK Ono Pharmaceutical Co.,Ltd. (Tokyo: 4528), Bristol-Myers Squibb Company (NYSE:BMY) and Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151,“Kyowa Hakko Kirin”) announced...
View ArticleClik here to view.
Seattle Genetics和武田在ASH年会上发布ADCETRIS® (Brentuximab...
旧金山 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社 (TSE:4502)今天发布了ADCETRIS (brentuximab vedotin)治疗复发或难治全身性间变性大细胞淋巴瘤(ALCL)枢纽性2期临床试验的4年总生存(OS)数据。ADCETRIS是一种靶向作用于CD30的抗体药物轭合物...
View ArticleClik here to view.
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the...
CHESHIRE, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Soliris® (eculizumab) has been granted orphan drug designation (ODD) by Japan’s Ministry of Health, Labour and...
View ArticleClik here to view.
Otsuka and Lundbeck’s Brexpiprazole Demonstrates Statistically Significant...
TOKYO & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced the presentation of Phase III study results evaluating the effects of an...
View ArticleClik here to view.
Wolters Kluwer Health Introduces UpToDate Anywhere Mobile Clinical Decision...
WALTHAM, Mass. Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today the Asian launch of UpToDate® Anywhere and its first...
View ArticleClik here to view.
FDA向MP Biomedicals签发有史以来首份HTLV证实性检测的核准书
加州圣安娜 (美国商业资讯)–生命科学试剂、精细化学品和诊断产品的领先提供商MP Biomedicals, LLC今天宣布，FDA已向该公司签发了MP Diagnostics HTLV（亲人类T淋巴细胞病毒）Blot 2.4检测的核准书，该检测采用Western 印迹法验证HTLV，并对病毒类型进行鉴别。这是美国有史以来首款获得FDA核准的HTLV证实性检测。 MP...
View ArticleClik here to view.
International Research on the Dorsal Root Ganglion (DRG) Presented at the...
LAS VEGAS At the 18th annual North American Neuromodulation Society (NANS) congress, researchers presented 20 international, peer-reviewed scientific abstracts from Australia and Europe highlighting...
View ArticleClik here to view.
MPバイオメディカルがHTLV確認アッセイ製品として初のFDA承認を取得
米カリフォルニア州サンタアナ （ビジネスワイヤ）–ライフサイエンス試薬、ファインケミカル製品、診断用製品を供給する一流企業のMPバイオメディカルは本日、「MPダイアグノスティックスHTLV（ヒトTリンパ球好性ウイルス）ブロット2.4（MP Diagnostics HTLV Blot...
View ArticleClik here to view.
Orion Health™ Completes $125 Million IPO in New Zealand
BOSTON Orion Health, a leading population health management company, announced that shares of Orion Health Group Limited (Orion Health, the Company) began trading on the NZX Main Board and ASX...
View ArticleClik here to view.
Australia’s Largest Life Insurer Partners with Healthways to Promote...
NASHVILLE, Tenn. & SYDNEY TAL, Australia’s largest specialty life insurer, has partnered with global well-being improvement leader Healthways, Inc. (NASDAQ: HWAY), to offer well-being...
View ArticleClik here to view.
Independent Study Demonstrates Stroke Patients Experience Superior Outcomes...
ALAMEDA, Calif. Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that...
View ArticleClik here to view.
ジェイアイエヌが開発中のJINS MEMEを「CES2015」に初出展
東京 （ビジネスワイヤ） — 株式会社ジェイアイエヌ（東京本社：東京都千代田区、代表取締役社長：田中 仁）は、2015年1月6日（火）～1月9日（金）まで米国ネバダ州・ラスベガスで開催される、コンシューマ・エレクトロニクス分野で世界最大の見本市「2015 International CES（コンシューマー･エレクトロニクス･ショー）」（以下、CES）に初出展いたします。 JINS MEME...
View ArticleClik here to view.
Ossianix扩大并延长与灵北在CNS治疗研究领域的合作
费城 (美国商业资讯) — Ossianix, Inc.今天宣布扩大并延长与丹麦灵北制药公司(H. Lundbeck A/S)（简称“灵北”）的战略研究合作。此次合作之前的合作包括2012年的资产投资和2013年的研究合作。合作将采用Ossianix基于鲨鱼VNAR结构的创新单域抗体平台，以投放下一代CNS生物治疗药物。...
View Article